Zevra Therapeutics Inc

XNAS:ZVRA 4:00:00 PM EDT

10.03

-0.46 (-4.38%)

7:59:53 PM EDT: $10.15 +0.12 (+1.20%)

Market Cap (Intraday)	566.95M
Current PE	4.64
Forward PE	9.93
2yr Forward PE	7.16

See more stats

Estimates Current Quarter

Revenue	$34.06 Million
Adjusted EPS	$0.11

See more estimates

10-Day MA	$10.42
50-Day MA	$10.06
200-Day MA	$9.41

See more pivots

Zevra Therapeutics Inc Stock, XNAS:ZVRA

1180 Celebration Boulevard, Suite 103, Celebration, Florida 34747

United States of America

Phone: +1.321.939.3416

Number of Employees: 59

http://zevra.com

Description

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.